About Us
Since its establishment in 1987, Pharmaline has been dedicated to the improvement of the lives of men, women, and children region-wide. A Lebanese pharmaceutical company, we are ranked among the top 15 in the country by IMS. Pharmaline is a member of Malia Group.
Pharmaline offers a wide-range of branded generics, from regular to super generics, which are manufactured at its expansive factory just north of Beirut.

Our commitment to quality and systems has allowed us to become the trusted licensee of multinational and regional companies including: Abbott, Exeltis, Glaxo SmithKline, Merck Serono, Novartis, Sandoz, Pierre Fabre, Tripharma, and Phadisco.

Pharmaline closely follows procedures outlined in Current Good Manufacturing Practices (cGMP), our facility meets EU standards and we also hold ISO 14001 certifications for Environmental Management System.

Thanks to a professional and dedicated marketing and sales force, we also export to countries throughout the Middle East, GCC, North Africa, Russia, and Europe.

With a keen eye on the future, Pharmaline believes in the development of its talent, customer relations, and partnerships – ensuring its permanence and continuous rise in the pharmaceutical industry.

Our Mission

At Pharmaline, we’ve made it our mission to be a leader in the betterment of human life through the continuous production of high-quality and affordable generic medicines. We will endeavor to continue being the trusted licensee of pharmaceutical multinationals looking for excellence in manufacture and regional marketing.

Our Vision

As industry leaders, we will strive to always provide patients, healthcare professionals, and partners with excellence in products and service. We will accomplish this by following a clear and dedicated path that includes:

Being Solution Providers

We aim to continue being solution providers for patients, healthcare providers, and international partners in local and export markets.

Acquiring Local & International Licenses

With a long history in attracting illustrious licenses, we look to persist in the same vein by updating our portfolio in view of being the first branded generic to enter the market and cementing partnership agreements.

Maintaining Our Competitive Edge

We will remain competitive and be a benchmark in the industry by providing high-quality medicines affordable to all.

Research & Development Frontrunners

With a focus on R&D, we work towards the continuous development of differentiated products, we excel in the domain through collaborative studies with reputable institutions in the field of science.

History

The vision for Pharmaline began in 1936 when Dr. Jean Michel Sarraf created local preparations of medicines and the filling of prescriptions in his small, yet thriving pharmacy in the North of Lebanon. Since then, his ambitions have grown to encompass a groundbreaking pharmaceutical company known internationally for its quality standards and its portfolio.
  • 1936
    Dr. Jean Michel Sarraf establishes Sarraf Pharmacy in North Lebanon.
  • 1951
    Le Comptoir National de la Droguerie Sarraf opens in Beirut and begins to distribute pharmaceutical and cosmetic products in Lebanon, Syria and Iraq.
  • 1987
    Pharmaline is created to produce branded products and becomes part of Malia Holding.
  • 1994
    License Agreement with Pierre Fabre (France) is signed.
  • 1998
    Pharmaline launches Aspicot, its leader product into the market.
  • 1999
    Pharmaline is awarded ISO 14001 certification for Quality Environment Systems.
  • 1999
    Pharmaline releases Flunazol, the most-prescribed anti-fungal medicament in Lebanon.
  • 2003
    License Agreement with Merck KGaA (Germany) is signed.
  • 2005
    License Agreement with Tripharma (Turkey) is signed.
  • 2005
    Pharmaline launches Muscerol, Lebanon's most requested analgesic muscle relaxant medicament.
  • 2005
    License Agreement with Phadisco (Cyprus) is signed.
  • 2008
    License Agreement with Abbott (USA) is signed.
  • 2009
    Plant expansion in line with EU norms.
  • 2010
    Agreement with GSK (UK) is signed.
  • 2011
    License Agreement with Novartis is signed.
  • 2014
    License Agreement with Sandoz is signed.
  • 2017
    License agreement with Exeltis (Spain) is signed.
  • 2018
    Plant expansion with view to increase capacity.

Global Presence

We export our branded generics and offer support to our licensors in the below countries

Manufacturing Facilities

Located in an industrial area just 20 km north of Beirut in Nahr Ibrahim, Pharmaline’s manufacturing site includes skilled, talented, highly trained and experienced staff operating state-of-the-art modern high capacity machinery following manufacturing practices that are cGMP certified. The site can be operational 24 hours/day; the system is operated under Oracle Process Manufacturing (OPM). Pharmaline has expanded its facilities in line with the EU norms requirements. All units are operating in a cGMP controlled and monitored environment under a stringent documented quality assurance system.

Production Division

  • Solid Form Division
    The Solid Manufacturing Division produces the below forms in three basic parts that include granulation, tablet press, and coating: Tablets, Enteric-coated tablets, Sustained Release tablets, Bilayer tablets, Capsules, Powders
    + Read More
    A - Manufacturing

    The Solid Manufacturing Division produces the below forms in three basic parts that include granulation, tablet press, and coating:

    • Tablets
    • Enteric-coated tablets
    • Sustained Release tablets
    • Bilayer tablets
    • Capsules
    • Powders
    B - packaging

    The bulk is packed by high-capacity, fully-automated machinery

  • Semi Solid Division
    At the Semi Solid Manufacturing Division the following forms are produced: Creams, Ointments, Gels
    + Read More
    A - Manufacturing

    At the Semi Solid Manufacturing Division the following forms are produced:

    • Creams
    • Ointments
    • Gels
    B - Packaging

    The bulk is packed by high-capacity, fully-automated machinery.

  • Liquid Form Division
    At the Liquid Manufacturing Division the following forms are produced: Syrup, Solution, Suspension, Medicated Shampoo
    + Read More
    A - MANUFACTURING

    At the Liquid Manufacturing Division the following forms are produced:

    • Syrup
    • Solution
    • Suspension
    • Medicated Shampoo
    B - PACKAGING

    The bulk is packed by high-capacity, fully-automated machinery.

  • Quality Assurance Division

    Pharmaline is committed to excellence through quality performance.
    + Read More

    Pharmaline is committed to excellence through quality performance. We view quality as our collective responsibility.

    Our facility is staffed with a team of highly experienced quality experts to ensure compliance.

    Pharmaline has established and continues to maintain an effective documented Quality Management System designed and implemented to fulfill the requirements of international standards and cGMP. 

  • Warehouse Division

    Our warehouses strictly comply with the FEFO System.
    + Read More

    Our warehouses strictly comply with the FEFO System.

    The warehouses' environment conditions are continuously controlled and monitored as per cGMP requirements (temperature/humidity). 

    Moreover, stock management is fully computerized under Oracle to ensure accurate delivery.